About US
History
HL Genomics
A Relentless Journey
toward Human Health
Following a legacy of trust built on differentiated synthesis expertise,
we are advancing as a global leader
dedicated to opening a healthier future for humanity.
2024
06
Exported to Indonesia
(Pantoprazole sodium sesquihydrate)
Renewal of Foreign Manufacturer Accreditation
(MHLW, Japan)
02
MFDS Routine Inspection Approval
(on-site, Korea, all products)
2023
12
PMDA Routine Inspection Approval
(on-site, Japan, Bepotastine Besilate)
2022
03
Vendor Audit by Sophia
(on-site, Mexico, Bepotastine Besilate)
2020
12
Established Dedicated R&D Department
2019
07
Expansion of Finished Product and Raw Material Warehouse
2017
09
PMDA Inspection Approval
(on-site, Japan, Bepotastine Besilate)
04
JDMF Registration (Bepotastine Besilate)
2014
09
Exported to Japan
(Pitavastatin dioxane t-butylester compound & Bepotastine Besilate)
06
Foreign Manufacturer Registration (MHLW, Japan)
2011
03
Exported to Colombia (S-amlodipine nicotinate)
2007
08
BGMP Certification by KFDA (now MFDS)
02
Completion of API Manufacturing Facility
2000